The study find that the soft tissue sarcomas are rare neoplasms, and most plastic surgeons do not commonly resurface large tissue defects after a wide resection of these tumors. The purpose of this study is to elucidate the clinical results of large skin grafts after wide sarcoma resection by comparison with grafts for traumatic skin defects. Coverage procedures for large soft tissue defects include primary closure, skin grafts (SGs), local flaps; regional flaps, and free tissue transfer. Of these options, skin grafting is a simple, effective procedure for wound coverage commonly used in trauma; wound infection, and resection of skin carcinoma.
Most plastic surgeons
Skin grafting can also be use for wound coverage after wide resection of soft tissue sarcomas; and adequate soft tissue reconstruction is critical to surgical success. Because sarcoma is a rare carcinoma ;patients with a suspect soft tissue or bone sarcoma are generally refer to the regional soft tissue sarcoma unit to be manage by a multidisciplinary team of sarcoma specialists. Therefore; the use of SGs in resurfacing large tissue defects is generally unfamiliar to most physicians except those in the regional units.
The wound bed after sarcoma resection has different characteristics from those of other conditions in which skin grafting is indicate. Because sarcomas arise from subcutaneous or deeper tissues and are excise along with at least 1 to 2 cm of the normal tissue surrounding the tumor, the wound is far deeper than after skin carcinoma removal. There is generally no wound bed preparation in sarcoma resection because; in principle, reconstruction achieve as a 1-stage procedure at the time of resection. Resection wounds are make by deliberate, sharp dissection in the operating room and are sterile; unlike wounds from trauma, burn, or infection, which can be contaminate, crushed, and lacerated.
Normal tissue surrounding
Based on these facts, the authors think skin grafting after sarcoma resection should be given particular attention; however, there is little information about its use in resurfacing large defects. The purpose of this study is to elucidate the characteristics and clinical results of large SGs for the reconstruction of tissue defects resulting from sarcoma resection by comparing them to SGs for traumatic skin defects.
With approval of the Kyushu University Institutional Review Board for Clinical Research (Fukuoka, Japan) and written informed consent from patients, a retrospective review was performed of patients who received SGs > 50 cm2 for wound closure of sarcoma resection defects or traumatic skin defects from January 1, 2014; to December 31, 2016. Patient medical records are review, and the following data are retrieve: age, gender, comorbidities, smoking status; size and site of the SG, secondary procedures, postoperative immobilization method, duration of immobilization; and day of complete epithelialization.